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UNIT 4.14Solid-Phase Synthesis of Branched
Oligonucleotides
This unit describes the synthesis of nucleic acids containing vicinal 2′,5′- and 3′,5′-phos-
phodiester bonds. These molecules occur in the cell nucleus, and are formed during the
splicing of precursor messenger RNA (pre-mRNA). As such they have many potential
applications in nucleic acid biochemistry, particularly as tools for probing the substrate
specificity of lariat debranching enzymes, and as tools for studying pre-mRNA splicing
(e.g., Nam et al., 1994; Carriero et al., 2001). The assembly of these branched nucleic
acids (bNAs) on a solid support can be achieved by following two strategies (Damha and
Zabarylo, 1989; Braich and Damha, 1997). The first, referred to as the convergent strategy,
is based on well-established automated phosphoramidite chemistry (UNITS 3.3 & 3.5). This
method uses a ribonucleoside bisphosphoramidite as the branch-introduction synthon (see
Basic Protocol 1). The branching reagent serves to couple together solid-support-bound
chains, thus forming a branch juncture with the desired vicinal 2′,5′- and 3′,5′-phosphodi-
ester bonds (see Basic Protocol 2). For efficient branching to occur, CPG supports with
high nucleoside loadings are used (see Support Protocol 1). With this approach, Y- and
V-shaped molecules having identical 2′ and 3′ chains are readily assembled.
The second method is a divergent approach that permits the regiospecific synthesis of
bNAs using readily available phosphoramidite reagents (see Basic Protocol 3). An
important feature of this method is the assembly of a linear DNA:RNA chimera containing
a single 2′-O-silylribonucleoside residue in the middle of the chain. Subsequent removal
of the 2-cyanoethyl and silyl protecting groups without detaching the nascent oligonu-
cleotide from the solid support is another salient feature of this approach. This releases
an internal 2′-OH group from which orthogonal synthesis of a branch can be carried out.
This unit also describes methods used in the authors’ laboratory for the deprotection (see
Support Protocol 2), purification, and characterization of branched oligonucleotides.
Preferred methods for purification of bNAs are anion-exchange HPLC (see Support
Protocol 3) and polyacrylamide gel electrophoresis (see Support Protocol 4). The
branched nature of the molecule is confirmed by enzymatic hydrolysis of the bNA to its
constituent nucleosides using nuclease P1 (see Support Protocol 3). Further charac-
terization may be conducted via nucleoside composition analysis using snake venom
phosphodiesterase (UNIT 10.6) or MALDI-TOF-MS (UNIT 10.1).
BASIC
PROTOCOL 1
SYNTHESIS AND CHARACTERIZATION OF THE ADENOSINE
BRANCHING SYNTHON N6-BENZOYL-5′-O-(4,4′-DIMETHOXYTRITYL)-
ADENOSINE-2′,3′-BIS-O-(2-CYANOETHYL-N,N-DIISOPROPYL)
PHOSPHORAMIDITE
The authors’ group has been predominantly interested in the synthesis of branched RNA
fragments related to the lariat intermediates formed during pre-mRNA splicing. Such
intermediates contain almost exclusively adenosine at the branch point; therefore, the
protocol given below describes the synthesis of the adenosine branching phosphoramidite
synthon (BIS-A; S.3; Fig. 4.14.1) used for the synthesis of symmetrical, branched DNA
and RNA oligonucleotides (Damha and Ogilvie, 1988). The same protocol may be
adapted to the synthesis of the corresponding U, C, and G bisphosphoramidites.
The starting protected nucleoside, N6-benzoyl-5′-O-(4,4′-dimethoxytrityl)adenosine
(S.1), is commercially available (ChemGenes). Alternatively, it may be synthesized from
adenosine using the transient benzoylation procedure of Ti et al. (1982), followed by
dimethoxytritylation of the 5′-hydroxyl group (Hakimelahi et al., 1982; Wu et al., 1989).
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The synthesis of the branching synthon involves the phosphitylation of the 2′ and 3′
secondary hydroxyls of the ribose sugar (Fig. 4.14.1) using an excess of 2-cyanoethyl-
N,N-diisopropylchlorophosphoramidite (S.2). Reaction conditions, workup, chroma-
tographic purification, and characterization of the product N6-benzoyl-5′-O-(4,4′-di-
methoxytrityl)adenosine-2′,3′-bis-O-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
(S.3) are described.
Materials
N6-Benzoyl-5′-O-(4,4′-dimethoxytrityl)adenosine (S.1; ChemGenes)
4-Dimethylaminopyridine (DMAP; 99%; Aldrich)
Nitrogen or argon gas, dry
Anhydrous THF (see recipe) in a septum-sealed distillation collection bulb
Anhydrous DIPEA (see recipe)
2-Cyanoethyl-N,N-diisopropylchlorophosphoramidite (S.2; ChemGenes)
1:1 (v/v) dichloromethane/diethyl ether
20% (v/v) sulfuric acid (optional)
Ethyl acetate prewashed with 5% (w/v) NaHCO3
NaCl solution, saturated
Sodium sulfate (Na2SO4), anhydrous
50:47:3 (v/v/v) CH2Cl2/hexanes/triethylamine
Silica gel (230- to 400-mesh) in 50:47:3 CH2Cl2/hexanes/triethylamine
95% (v/v) ethanol
Diethyl ether
50-mL oven- or flame-dried round-bottom flask with rubber septum
Glass syringe and needle, oven dried
2 × 5 cm silica-coated thin-layer chromatography (TLC) plate with fluorescent
indicator (e.g., Kieselgel 60 F254 aluminum sheets)
254-nm UV light source
500-mL separatory funnel
Gravity filtration device and filter paper
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Figure 4.14.1 Reaction scheme demonstrating the synthesis of N6-benzoyl-5′-O-(4,4′-dimethoxytrityl)adenosine-2′,3′-O-
bis-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite (S.3) from the starting protected nucleoside N6-benzoyl-5′-O-(4,4′-di-
methoxytrityl)adenosine (S.1). The structure of the chlorophosphoramidite (S.2) is also shown. Abbreviations: Bz, benzoyl;
DIPEA, N,N-diisopropylethylamine; DMAP, 4-dimethylaminopyridine; DMTr, 4,4′-dimethoxytrityl.
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250- and 500-mL round-bottom flasks
Rotary evaporator with a water aspirator
5 × 25–cm glass chromatography column with solvent reservoir bulb
Additional reagents and materials for thin-layer chromatography (TLC; APPENDIX
3D), column chromatography (APPENDIX 3E), 31P-NMR (UNIT 7.2), and mass
spectrometry (UNITS 10.1 & 10.2)
Phosphitylate 2′- and 3′-OH
1. Place 1.3 g (2.0 mmol) N6-benzoyl-5′-O-(4,4′-dimethoxytrityl)adenosine (S.1) and
84 mg (0.7 mmol) DMAP into a 50-mL oven- or flame-dried round-bottom flask.
2. Cap the flask with a rubber septum and purge the flask with dry nitrogen or argon.
Care must be taken to avoid the presence of moisture throughout the entire reaction.
3. Withdraw anhydrous THF from a septum-sealed distillation collection bulb using an
oven-dried glass syringe and needle. Add 6.0 mL THF to the purged flask with stirring
until the starting material is completely dissolved.
4. Add 3.6 mL (21 mmol) anhydrous DIPEA and stir the mixture.
5. Slowly add 1.8 mL (8.3 mmol) 2-cyanoethyl-N,N-diisopropylchlorophosphoramidite
(S.2).
If the THF solution is sufficiently dry, a white precipitate should form after ∼1 min. This is
the diisopropylethylammonium hydrochloride salt that forms during the reaction.
6. Stir the mixture 1 hr at room temperature or until the reaction is complete.
Reaction of the secondary hydroxyls of the starting material with S.2 is fast. If TLC analysis
(see below) reveals that the reaction is not complete after 1 hr, a further 0.5 mmol S.2
should be added dropwise and stirring continued until all of the starting material is
consumed.
Monitor reaction by TLC
7. Spot the reaction mixture onto a precut 2 × 5–cm silica-coated TLC plate with
fluorescent indicator and develop using 1:1 (v/v) dichloromethane/diethyl ether
(APPENDIX 3D).
Addition of 1% to 3% trietylamine may help prevent detritylation.
8. Visualize heterocyclic bases under a 254-nm UV light source. If desired, spray the
plate with 20% sulfuric acid in order to visualize the dimethoxytrityl-bearing species.
CAUTION: Wear protective eyewear.
TLC analysis should indicate complete conversion to products, which exhibit larger Rf
values than the starting protected nucleoside. Since the phosphitylation reaction gives rise
to two new chiral centers (2′- and 3′-P), the product (S.3) consists of a mixture of four
diastereomers. The products appear as two spots (Rf = 0.51 and 0.40) or as one dumbbell-
shaped spot, because the solvent system partially resolves the four diastereomeric products.
A minor side product forms, which migrates between the product (S.3) and starting material
(S.1). This is likely the nucleoside-2′,3′-H-bis-phosphonate (Rf = 0.25) that forms via
hydrolysis of S.3.
Work up reaction
9. Transfer the reaction mixture to a 500-mL separatory funnel and add 100 mL
prewashed ethyl acetate.
The ethyl acetate is prewashed with 5% NaHCO3 in order to prevent detritylation and/or
activation of the phosphoramidite moiety.
10. Wash the ethyl acetate layer five times each with 100 mL saturated NaCl solution.
The diisopropylammonium hydrochloride salt dissolves.
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11. Dry the organic layer over anhydrous Na2SO4. Add more Na2SO4 if the salt crystals
clump together upon swirling.
When the solution is dry, the nonhydrated crystals will float in solution upon swirling.
12. Gravity filter the resulting solution through filter paper into a 250-mL round-bottom
flask. Rinse the Na2SO4 crystals with 10 to 20 mL ethyl acetate.
13. Remove the solvent under reduced pressure (i.e., in a rotary evaporator with a water
aspirator) to yield the crude product as a yellow oil.
Isolate and characterize product
14. Prepare a 5 × 25–cm glass chromatography column by adding a slurry of 40 g silica
gel in 50:47:3 CH2Cl2/hexanes/triethylamine. Precondition with the same solvent.
15. Dissolve the crude material in a minimum amount of 50:47:3 CH2Cl2/hex-
anes/triethylamine and load on column. Perform chromatography at a rate of ∼1 in.
solvent/min using a small amount of air pressure (APPENDIX 3E). Collect product in
10-ml fractions in small test tubes.
16. Combine product-containing fractions into a 500-mL round-bottom flask and con-
centrate to an oil on a rotary evaporator.
17. Remove residual triethylamine by co-evaporating the oil first with 50 mL of 95%
ethanol followed by 50 mL diethyl ether, to provide the pure product as a pale yellow
foam.
18. Store bisphosphoramidite at –20°C under an inert atmosphere protected from light.
Phosphoramidites are particularly sensitive to UV light; therefore, it is best to store the
bisphosphoramidite in a dark bottle (or a bottle covered with aluminum foil) in a –20°C
freezer. Under these conditions, the phosphoramidite may be stored for an indefinite period
of time. Prior to use, its purity may be verified via TLC analysis. If partial decomposition
has occurred, or the coupling reactions with S.3 are poor, the compound should be
subjected to chromatography again as described above.
19. Characterize by TLC (APPENDIX 3D), 31P-NMR (UNIT 7.2), and mass spectrometry (UNITS
10.1 & 10.2).
31P-NMR spectra (400 MHz) of S.3 were measured on a Varian XL-400 spectrometer using
CD3CN as the solvent (Fig. 4.14.2). Chemical shifts are reported in parts per million (ppm)
and are downfield (positive value) from 85% H3PO4 (external standard). Fast atom
bombardment mass spectrometry (FAB-MS) analysis was conducted on a Kratos MS25RFA
high-resolution mass spectrometer using a p-nitrobenzyl alcohol (NBA) matrix.
N6-Benzoyl-5′-O-(4,4′-dimethoxytrityl)adenosine-2′,3′-bis-O-(2-cyanoethyl-N,N-diiso-
propylphosphoramidite) (S.3): yield 52% (560 mg); Rf (1:1 CH2Cl2/diethyl ether): 0.51
and 0.40; 31P-NMR (400 MHz, CD3CN): diastereomer 1, 152.3 and 150.7 ppm (5JP-P =
10.1 Hz); diastereomer 2, 151.9 and 150.5 ppm (5JP-P = 6.6 Hz); diastereomer 3, 151.8
and 151.0 ppm (5JP-P = 4.6 Hz); diastereomer 4, 151.3 and 151.2 ppm (5JP-P = 8.9 Hz);
FAB-MS anal. calc’d.: 1074.17; observed: 1074.57; [M]+.
BASIC
PROTOCOL 2
CONVERGENT SYNTHESIS OF SYMMETRICAL BRANCHED NUCLEIC
ACIDS
The procedure described below for the synthesis of bNAs is carried out on a 1-µmol scale
using an ABI 381A DNA synthesizer (Damha and Zabarylo, 1989; Damha et al., 1992).
The condensation of two adjacent linear oligonucleotides (prepared from standard RNA
or DNA phosphoramidites; Fig. 4.14.3) with the adenosine bisphosphoramidite synthon
(S.3; Fig. 4.14.1) produces bNAs that contain identical branches connected via vicinal
2′,5′- and 3′,5′-phosphodiester linkages (Fig. 4.14.4). The same protocol may be utilized
for the synthesis of bNAs containing D-xylose or D-arabinose instead of D-ribose at the
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branchpoint, using the appropriate bisphosphoramidite synthons (Damba and Ogilvie,
1988; Noronha, Carriero, Agha, and Damha, unpub. observ.).
Branched nucleic acid synthesis works very well on commercially available solid supports
(i.e., LCAA-CPG) containing 20 to 40 µmol nucleoside per gram support; however, even
better yields are attainable on CPG supports with higher loadings (e.g., 90 µmol/g; Fig.
4.14.5). Such supports can be prepared using HATU/DMAP as the coupling reagents (see
Support Protocol 1), and are ideal for the synthesis of short-length bNAs (e.g., trimers)
since, in this case, high loadings ensure proper distance between the neighboring CPG-
bound nucleosides (Damha and Zabarylo, 1989).
Materials
5′-O-(4,4′-Dimethoxytrityl)-N-protected-2′-deoxyribonucleoside- or
-ribonucleoside-derivatized succinyl-LCAA-CPG (ChemGenes; also see
Support Protocol 1)
Cap A and B capping reagents (see recipes)
DNA and/or RNA 3′-phosphoramidites (S.4a-d and S.5a-d; Fig. 4.14.3)
152.5 152.0 151.5 151.0 150.5 PPM
2
2
4 4
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Figure 4.14.2 31P-NMR of N6-benzoyl-5′-O-DMTr-adenosine-2′,3′-bis-O-(2-cyanoethyl-N,N-di-
isopropyl)phosphoramidite (S.3). Due to the two chiral phosphorus centers, the compound exists
as a mixture of four diastereomers (22 = 4; Fig. 4.14.1). Each diastereomer displays two sets of
phosphorus signals (4 isomers × 2 31P signals = 8 signals). The doubling or splitting of each signal
(8 × 2 = 16) is due to long-range coupling between the two chiral 31P atoms (nuclear spin = 1⁄2) of
the bisphosphoramidite. The spectrum was recorded on a Varian XL-400 spectrometer using
CD3CN as the solvent. The chemical shift and coupling constants for the four diastereomers (shown
as numbers near peaks) are as follows: diastereomer 1, 152.3 and 150.7 ppm (5JP-P = 10.1 Hz);
diastereomer 2, 151.9 and 150.5 ppm (5JP-P = 6.6 Hz); diastereomer 3, 151.8 and 151.0 ppm (5JP-P
= 4.6 Hz); diastereomer 4, 151.3 and 151.2 ppm (5JP-P = 8.9 Hz).
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N6-Benzoyl-5′-O-(4,4′-dimethoxytrityl)adenosine-2′,3′-bis-O-(2-cyanoethyl-N,N-
diisopropyl)phosphoramidite (BIS-A; S.3; see Basic Protocol 1)
Anhydrous acetonitrile (see recipe)
Activator solution: 0.5 M 1H-tetrazole (sublimed) in anhydrous acetonitrile
Oxidant solution (see recipe)
Detritylation solution (see recipe)
Nitrogen or argon gas (optional)
Synthesis columns for 1-µmol scale synthesis, with seals and filters (PE
Biosystems) and 13-mm aluminum seals (Chromatographic Specialties)
ABI 381A automated DNA synthesizer (PE Biosystems)
Synthesizer bottles for phosphoramidites, oven dried
Fraction collector and 15-mL test tubes
50-mL buret
Quartz cuvettes
UV-Vis spectrophotometer
Additional reagents and equipment for oligonucleotide synthesis (APPENDIX 3C),
cleaving and deprotecting oligonucleotides (see Support Protocol 2), and
anion-exchange HPLC (see Support Protocol 3) or denaturing PAGE (see
Support Protocol 4)
NOTE: 1H-Tetrazole is no longer commercially available in crystalline form. Solutions
of 0.45 M 1H-tetrazole in anhydrous acetonitrile may be purchased from ChemGenes.
For a list of supplementary phosphoramidite activating reagents, see UNIT 3.5.
CAUTION: All solutions for the DNA/RNA synthesizer should be prepared in a well-ven-
tilated fume hood.
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Figure 4.14.3 Chemical structures of DNA and RNA phosphoramidites used for bNA synthesis:
5′-O-DMTr-N-protected-2′-deoxyribonucleoside-3′-O-(2-cyanoethyl-N,N-diisopropylamino)phos-
phoramidites (S.4a-d), 5′-O-DMTr-N-protected-2′-O-TBDMS-ribonucleoside-3′-O-(2-cyanoethyl-
N,N-diisopropylamino)phosphoramidites (S.5a-d), and the inverted phosphoramidites 3′-O-DMTr-
N-protected-2′-deoxyribonucleoside-5′-O-(2-cyanoethyl-N,N-diisopropylamino)phosphoramidites
(S.6a-d).
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Prepare columns for synthesis
1. Transfer an accurately weighed amount of 5′-O-(4,4′-dimethoxytrityl)-N-protected-
2′-deoxyribonucleoside- or -ribonucleoside-derivatized succinyl-LCAA-CPG for a
1-µmol synthesis to an assembled synthesis column.
The support-bound nucleoside represents the first nucleotide at the 3′-end of the oligonu-
cleotide to be synthesized. See Support Protocol 1 for high-loading CPG supports.
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Figure 4.14.4 Schematic representation demonstrating the convergent synthesis of V- and Y-
shaped bDNA or bRNA oligonucleotides on a solid support. The method can also be used for the
synthesis of short branched sequences—e.g., tetranucleoside triphosphates, NpA(2′pN)3′pN—
particularly when the nucleoside loading on the solid support approaches 90 µmol/g. Abbreviations:
A, bisphosphoramidite; Bz, benzoyl; DMTr, 4,4′-dimethoxytrityl; N, any nucleotide (RNA or DNA);
TREAT-HF, triethylammonium trihydrofluoride; S.7, linear oligonucleotide; S.8 and S.10, full-length
bNAs (V- and Y-shaped); S.9a-b and S.11a-b, unbranched linear failure sequences. P* indicates
the presence of a 2′- or 3′-linked phosphate to the adenosine branch point, which is formed by the
hydrolysis and oxidation of the residual phosphoramidite during solid-phase synthesis.
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Figure 4.14.5 Effect of CPG loading on yield of the Y-shaped bDNA, T10A2′,5′-T10 3′,5′-T10 synthesized via the convergent
strategy (see Basic Protocol 2). (A) PAGE analysis of the amount of Y-shaped product (i; S.10) and failure sequences (ii;
S.11a-b) formed as a function of CPG loading on a 20% denaturing polyacrylamide gel. P* indicates the presence of a 2′-
or 3′-linked phosphate. (B) Chart demonstrating the increase in the amount of S.10 (i) with increasing nucleoside-CPG
loading. The chart also demonstrates the inverse relationship between the amount of extended isomeric linear failures (ii;
S.11a-b) and nucleoside-CPG loading. The percentage oligonucleotide was determined by integration of the HPLC peak
areas of the compounds in question (see Support Protocol 3) using gradient 3 (see Table 4.14.4).
Table 4.14.1 Automated Cycle on an ABI 381A DNA Synthesizer for Capping of Free
CPG-Bound Amino and Hydroxyl Groupsa
Synthesis step Function Time (sec)
Column washing steps:
1 Acetonitrile to waste   5
2 Acetonitrile to column  60
3 Argon reverse flush   5
4 Argon block flush   5
Column capping steps:
5 Cap A + cap B to column  15
6 Wait 300
7 Repeat steps 5 and 6    
Column washing steps:    
8 Argon reverse flush   5
9 Acetonitrile to column  30
10 Repeat steps 8 and 9    
11 Argon reverse flush   5
12 Argon block flush   5
aAlternatively, CPG may be capped manually using acetic anhydride (see Support Protocol 1).
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2. Acetylate any underivatized amino and hydroxyl groups on the solid support using
an ABI 381A automated DNA synthesizer and the capping cycle given in Table 4.14.1
(APPENDIX 3C).
This step also removes traces of water from the solid support.
Alternatively, see Support Protocol 1 for the manual capping procedure on nucleoside-
loaded CPG.
Synthesize branched oligonucleotides
3. Weigh out the appropriate amount of DNA (S.4a-d) and/or RNA (S.5a-d) 3′-phos-
phoramidites (Fig. 4.14.3) and dilute to the appropriate concentration with anhydrous
acetonitrile as indicated in Table 4.14.2.
4. Transfer 100 mg BIS-A (S.3) to an oven-dried synthesizer bottle and dilute to 0.03
M with anhydrous acetonitrile.
Low concentrations of BIS-A should be employed in the branching reaction, as high
concentrations minimize the yield of fully branched product (S.8 and S.10) and favor the
extended isomeric side products (S.9a-b and S.11a-b).
It is important to prepare the BIS-A stock solution using ≥100 mg material to ensure that
(unavoidable) traces of moisture do not consume significant amounts of BIS-A during the
coupling (branching) step and reduce the overall yield of bNA synthesis (Fig. 4.14.6E).
When the ABI 381A DNA synthesizer is used, this stock solution can be used for as many
as 18 branching reactions (170 L/addition). Once bNA synthesis is complete, the bottle
containing the BIS-A reagent can be removed from the synthesizer, sealed, purged under
an inert atmosphere, and left in a freezer (−20°C) for ∼2 weeks. Alternatively, the stock
solution can be evaporated under vacuum, and the solid bisamidite recovered for future
use.
5. Place all synthesizer reagents (i.e., activator, capping, oxidant, and detritylation
solutions, and acetonitrile) and diluted phosphoramidites (step 3) on the appropriate
ports of the synthesizer.
6. Place the BIS-A phosphoramidite bottle on the spare phosphoramidite port (the “X”
port on the 381A synthesizer).
Table 4.14.2 Concentrations and Optimal Coupling Times of Phosphoramidites in Synthesis
of bNAs on an ABI 381A DNA Synthesizer
Phosphoramiditea Mol. wt. (g/mol) Concentration(g/mL) Coupling time (sec)
DNA phosphoramidites (0.1 M in CH3CN b):
S.4a, S.6a  857.7  86   90
S.4b, S.6b  839.7  84  120
S.4c, S.6c  833.7  83   90
S.4d, S.6d  744.6  74   90
RNA phosphoramidites (0.15 M in CH3CN):
S.5a  988.2 148  600
S.5b  970.2 146  900
S.5c  964.2 145  600
S.5d  861.0 129  600
Bisphosphoramidite (0.03 M in CH3CN):
S.3 1074.2 32.2 1800
aPhosphoramidite structures are shown in Figure 4.14.3.
bFinal concentration of the first inverted DNA phosphoramidite coupled to the 2′-OH of the rA in divergent and
regiospecific synthesis is 0.3 M (see 5′-pD′′ in Fig. 4.14.8).
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Table 4.14.3 Automated 1-µmol Synthesis Cycle for bDNA and bRNA on an ABI 381A
DNA Synthesizer
Synthesis step Function Time (sec)
Detritylation of support-bound nucleoside:
 1 Acetonitrile to waste   5
 2 Acetonitrile to column  45
 3 Argon reverse flush   5
 4 Argon block flush   5
 5 Advance fraction collector   1
 6 3% TCA to waste  10
 7 3% TCA to column 140
 8 Acetonitrile to column  30
 9 3% TCA to column  80
10 Argon block flush  10
Column washing steps:
11 Acetonitrile to waste   5
12 Acetonitrile to column 120
13 Argon reverse flush   5
14 Argon block flush   5
15 Acetonitrile to waste   5
16 Acetonitrile to column  60
17 Argon reverse flush   5
18 Argon block flush   5
Phosphoramidite coupling steps:
19 Phosphoramidite preparation   3
20 Activator to column   5
21 Phosphoramidite + activator to
column
  5
22 Repeat steps 20 and 21 two times    
23 Activator to column   3
24 Waita    
25 Argon reverse flush   5
26 Argon block flush   5
Column capping steps:    
27 Cap A + cap B to column  17
28 Wait  45
29 Repeat steps 27 and 28    
30 Acetonitrile to waste   5
31 Argon block flush   5
32 Acetonitrile to waste   5
33 Argon reverse flush   5
34 Argon block flush   5
Oxidation steps:    
35 Oxidant to waste   5
36 Oxidant to column  20
37 Acetonitrile to waste   5
38 Argon block flush   5
39 Wait  20
Column washing steps:
40 Acetonitrile to waste   5
41 Argon reverse flush  10
42 Argon block flush   5
43 Acetonitrile to waste   5
44 Acetonitrile to column  18
45 Argon reverse flush   5
46 Repeat steps 44 and 45 six times    
47 Argon block flush   5
aSee Table 4.14.2 for coupling times of various phosphoramidites.
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7. Enter the sequence to be synthesized in the 5′-to-3′ direction, where the 3′-nucleotide
corresponds to the nucleoside bound to the CPG.
For example, to synthesize the hypothetical V-shaped branched oligonucleotide (S.8) shown
in Figure 4.14.4, enter the sequence 5′-XNNNNNN-3′, where X corresponds to the
bisphosphoramidite and N is any base (phosphoramidite) of choice. If the hypothetical
Y-shaped branched oligonucleotide (S.10)  is desired, enter the sequence 5′-
NNNNNNXNNNNNN-3′.
8. Perform synthesis in the trityl-off mode according to the synthesis cycle outlined in
Table 4.14.3 and utilizing the coupling times recommended in Table 4.14.2. Collect
dimethoxytrityl solutions in 15-mL test tubes using an external fraction collector.
Turning the trityl mode off ensures that the last nucleotide at the 5′ end has a free hydroxyl
group, which is desirable for purification using anion-exchange HPLC (see Support
Protocol 3).
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Figure 4.14.6 Analysis of bDNA and bRNA molecules synthesized using the convergent strategy (see Basic Protocol 2).
(A-B) Analysis of a successful synthesis of the Y-DNA 5′-T10A2′,5′-GT9 3′,5′-GT9 by (A) anion-exchange HPLC (see Support
Protocol 3) using gradient 3 (Table 4.14.4) and (B) 20% denaturing PAGE (see Support Protocol 4). (C-E) Analysis of a
successful (C-D) and unsuccessful (E) synthesis of the mixed base Y-RNA 5′-CCCUACUAA2′,5′-GUAUGCCC3′,5′-GUAUGCCC by
(C) anion-exchange HPLC (see A for conditions) and (D-E) 20% denaturing PAGE. The regioisomeric extended failure
sequences (ii) are resolved into two peaks by HPLC (A and C), but appear as one band by gel analysis (B, D, and E). In
panel E, the major product is the unbranched 8-mer 5′-GUAUGCCC-3′, which accumulates due to the unsuccessful
branching of the bisphosphoramidite. P* indicates the presence of a 2′- or 3′-linked phosphate.
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9. Upon completion of the synthesis, dry the CPG by manually conducting an argon
reverse flush operation on the synthesizer for 10 min. Alternatively, dry the CPG
under a stream of nitrogen or argon, or in a vacuum desiccator for 30 min.
10. Cleave the oligonucleotides from the support and deprotect the exocyclic amino,
phosphate, and 2′-silyl (RNA only) protecting groups (see Support Protocol 2).
11. Purify the bNAs from failure sequences by anion-exchange HPLC (see Support
Protocol 3) or denaturing PAGE (see Support Protocol 4).
Typical HPLC and PAGE profiles for the synthesis of branched V-shaped and Y-shaped
DNA and RNA molecules are demonstrated in Figures 4.14.6 and 4.14.7.
Measure branching efficiency by trityl color analysis
12. Dilute the dimethoxytrityl solutions collected after each successive coupling (step 8)
with 10 mL detritylation solution using a 50-mL buret.
13. Aliquot 100 µL into a quartz cuvette and dilute with 2 mL detritylation solution.
Use only quartz cuvettes, as the 1,2-dichloroethane will dissolve disposable polystyrene
cuvettes.
14. Measure the absorbance of the solution on a UV-Vis spectrophotometer between 450
and 550 nm, and record the absorbance peak at ∼505 nm for the dimethoxytrityl
cation.
d XC
BPB
a
c
a′
b
1 2 3 4
b
Figure 4.14.7 PAGE analysis of bDNA molecules synthesized via the convergent strategy (see
Basic Protocol 2), demonstrating the mobilities of bNAs through a cross-linked 20% polyacrylamide
gel. Lane 1, crude linear DNA 12-mer 5′-TACTAAGTATGT-3′ (a); lane 2, crude V-DNA 13-mer
5′-A2′,5′-GTATGT3′,5′-GTATGT (c); lane 3, crude Y-DNA 18-mer TACTAA2′,5′-GTATGT3′,5′-GTATGT (d); lane
4, running dyes (xylene cyanol and bromphenol blue). The fastest-migrating sequence in lanes 2
and 3 is the 6-mer 5′-GTATGT-3′ (b), which is the immediate precursor of the V-shaped molecule
(c). Notice the large gap between the failure sequence (b) and product V-DNA (c) in lane 2, owing
to more than doubling the molecular weight upon branching. In lane 3, extension of the failure
sequence yields a separate band (a′).
Supplement 9 Current Protocols in Nucleic Acid Chemistry
4.14.12
Solid-Phase
Synthesis of
Branched
Oligonucleotides
15. Determine the efficiency of each coupling step using the equation (Ax/Ax−1) × 100%,
where Ax is the absorbance of the trityl cation released at any given step and Ax−1 is
the release in the previous step.
For efficient coupling, these values should be close to 100% for linear portions of the
oligonucleotide (also see UNIT 10.3). For efficient branching, the value for the coupling of
S.3 should be 50%, since one tritylated bisphosphoramidite is coupled to two nucleotide
chains. For this step, trityl yields that are significantly greater than or less than 50%
indicate little branch formation (e.g., 80% indicates the formation of mainly the extended
isomeric compounds S.9a-d and S.11a-d).
BASIC
PROTOCOL 3
REGIOSPECIFIC SYNTHESIS OF BRANCHED NUCLEIC ACIDS
The protocol described below outlines the regiospecific and divergent synthesis of bNAs
via phosphoramidite chemistry according to the method of Braich and Damha (1997; Fig.
4.14.8). This protocol allows for the synthesis of bNA molecules with different DNA
sequences surrounding the branchpoint nucleotide. The methodology requires the use of
standard DNA and RNA 3′-phosphoramidites (S.4a-d and S.5a-d) for the synthesis of a
linear DNA strand incorporating a single ribonucleotide unit. Once this sequence is
assembled, all of the 2-cyanoethyl phosphate-protecting groups are selectively removed
by treatment with triethylamine. This step is necessary as phosphotriesters are susceptible
to cleavage/modification by the ensuing fluoride treatment. The CPG-bound oligomer is
then treated with fluoride ions to cleave the tert-butyldimethylsilyl group at the 2′ position
of the ribose unit, from which another chain (2′-branch) can be synthesized. This is
accomplished using “inverted” DNA phosphoramidites (deoxyribonucleoside 5′-phos-
phoramidites; S.6a-d), allowing branch synthesis to occur in the opposite (5′-to-3′)
direction. With the exception of the decyanoethylation and desilylation steps, the entire
process is conducted using an ABI 381A DNA synthesizer.
Materials
5′-O-(4,4′-Dimethoxytrityl)-N-protected-2′-deoxyribonucleoside-derivatized
succinyl-LCAA-CPG (ChemGenes; also see Support Protocol 1)
Cap A and B capping reagents (see recipes)
DNA 3′-phosphoramidites (S.4a-d; Chem Genes; Fig. 4.14.3)
Anhydrous acetonitrile (see recipe)
RNA 3′-phosphoramidite (S.5a-d; ChemGenes; Fig. 4.14.3)
Activator solution: 0.5 M 1H-tetrazole (sublimed) in anhydrous acetonitrile
Oxidant solution (see recipe)
Detritylation solution (see recipe)
4:6 (v/v) triethylamine/acetonitrile (see recipe)
Anhydrous THF (see recipe)
1 M tetra-n-butylammonium fluoride (TBAF; Aldrich) in THF, fresh
Inverted DNA 5′-phosphoramidites (S.6a-d; ChemGenes; Fig. 4.14.3)
Argon or nitrogen gas (optional)
Synthesis columns for 1 µmol scale synthesis, with seals and filters (PE
Biosystems) and 13-mm aluminum seals (Chromatographic Specialties)
ABI 381A automated DNA synthesizer (PE Biosystems)
External fraction collector and 15-mL test tubes
Empty DNA synthesizer bottles, oven-dried
10- and 1-mL disposable syringes
25-mL glass syringe
Additional reagents and equipment for cleaving and deprotecting the
oligonucleotide (see Support Protocol 2), anion-exchange HPLC (see Support
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Figure 4.14.8 Schematic representation for the divergent and regiospecific synthesis of branched
DNA. The branching synthon is a standard RNA phosphoramidite (S.5a-d; Fig. 4.14.3). Abbrevia-
tions: 3′-pD, DNA 3′-phosphoramidites (S.4a-d); 5′-pD′, inverted DNA 5′-phosphoramidites (S.6a-
d); 5′-pD′′, higher concentration (0.3M) of inverted DNA 5′−phosphoramidite as first nucleotide
coupled to the ribose branch point; 3′-pR, RNA 3′-phosphoramidite (S.5a-d); DMTr, 4,4′-di-
methoxytrityl; TBDMS, tert-butyldimethysilyl.
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Protocol 3) or denaturing PAGE (see Support Protocol 4), and measuring
coupling efficiency by trityl color analysis (see Basic Protocol 2)
CAUTION: All solutions required for bNA solid-phase synthesis should be prepared in a
well-ventilated fume hood.
Synthesize linear DNA (S.12)
1. Prepare synthesis column (1 µmol) with the appropriate 5′-O-dimethoxytrityl-2′-de-
oxyribonucleoside-derivatized succinyl-LCAA-CPG (see Basic Protocol 2, steps 1
and 2).
2. Weigh out the proper amount of DNA 3′-phosphoramidites (S.4a-d; Fig. 4.14.3) and
dilute to 0.1 M with anhydrous acetonitrile (see Table 4.14.2).
For synthesis on the ABI 381A DNA synthesizer, the volume of each phosphoramidite
addition to the column is 170 L.
3. Weigh out the appropriate amount of 3′-RNA phosphoramidite (S.5a-d; Fig. 4.14.3)
and dilute to 0.15 M with anhydrous acetonitrile (see Table 4.14.2).
The RNA 3′-phosphoramidite is the branching synthon. Any of the four standard RNA
3′-phosphoramidites (A, G, C, or U) may be used depending on the specific branch point
to be introduced.
4. Install all reagents (i.e., activator, capping, oxidant, and detritylation solutions, and
acetronitrile) and phosphoramidite solutions on the synthesizer, placing the RNA
3′-phosphoramidite on the spare port (the “X” port on the 381A synthesizer).
5. Enter the base sequence of the linear oligonucleotide to be synthesized in the 5′-to-3′
direction, where the last entry (3′ nucleotide) corresponds to the nucleoside bound
to the CPG.
For example, to synthesize the hypothetical linear oligonucleotide (S.12) shown in Figure
4.14.8, enter the sequence 5′-NNNNNNXNNNNNN-3′, where N is any deoxyribonucleoside
phosphoramidite and X represents the branch point of the RNA.
6. Perform synthesis in the trityl off mode according to the synthesis cycle outlined in
Table 4.14.3 and utilizing the coupling times shown in Table 4.14.2. Collect the
dimethoxytrityl solutions in 15-mL test tubes in an external fraction collector.
Turning the trityl mode off ensures that the last nucleotide at the 5′ end has a free hydroxyl
group, which is desirable for purification using anion-exchange HPLC (see Support
Protocol 3).
7. Acetylate the hydroxyl group at the 5′ terminus by running the automated capping
cycle (Table 4.14.1).
Capping the free 5′-OH is necessary as it ensures that extension from this functional group
will not occur during the synthesis of the “’orthogonal” 2′-branch.
Cleave 2-cyanoethyl protecting group
8. Dry the CPG by manually conducting an argon reverse flush operation on the
synthesizer for 10 min.
9. Remove the synthesis column from the synthesizer and connect it to a 10-mL
disposable syringe filled with 4:6 (v/v) triethylamine/acetonitrile. Slowly push the
deprotection solution through the column over a 90-min period.
Deprotection of the 2-cyanoethyl phosphate-protecting group converts the phosphotriester
to the more stable phosphodiester, which withstands the conditions required for desilylation
in the ensuing step. To ensure complete decyanoethylation, push the solution slowly through
the column and then pull in on the syringe slightly in order to displace the CPG beads from
the base of the column.
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10. Wash the CPG beads extensively with 30 mL acetonitrile followed by 30 mL THF
using a 25-ml glass syringe attached to the column via the syringe adapter.
Cleave 2′-O-TBDMS group
11. Push 1 mL of 1 M TBAF in THF through the column over a period of 10 min using
a 1-mL disposable syringe.
It is essential to use fresh TBAF. In order to ensure complete desilylation, push the solution
slowly through the column and then pull in on the syringe slightly in order to displace the
CPG beads from the base of the column. Prolonged treatment with TBAF results in cleavage
of the oligonucleotide chain from the solid support (Braich and Damha, 1997).
Incomplete desilylation results in the accumulation of silylated linear DNA (S.12; Fig.
4.15.8), which does not allow branch extension from the 2′ position of the branch point
(see Fig. 4.14.9B).
12. Wash CPG beads with 50 mL THF followed by 50 mL acetonitrile.
13. Reinstall the column on the synthesizer.
Synthesize 2′,5′-linked branch (S.13)
14. Modify the DNA synthesis cycle such that synthesis step 15 becomes the first step
in the cycle.
Steps 1 to 14 (TCA treatment) may be disregarded since the assembled chain lacks a
dimethoxytrityl group.
15. Weigh out the appropriate amounts of inverted DNA 5′-phosphoramidites (S.6a-d;
Fig. 4.14.3) into the amidite bottles. Add acetonitrile to the first DNA phophoramidite
to prepare a 0.3 M solution. Add acetonitrile to make 0.1 M solutions of each of the
remaining monomers.
The first inverted DNA 5′-phosphoramidite is added as a 0.3 M solution due to steric
hindrance around the ribose 2′-hydroxyl group.
16. Install all the inverted phosphoramidites on the synthesizer and place the first inverted
phosphoramidite (0.3 M concentration) on the spare port (the “X” port on the 381A).
17. Enter the linear sequence to be synthesized in the 5′-to-3′ direction, where the last
entry corresponds to the first phosphoramidite to be coupled to the 2′-hydroxyl of the
branch point.
For example, to synthesize the hypothetical branched DNA oligonucleotide (S.13) shown
in Figure 4.14.8, enter the sequence 5′-NNNNNN-3′, where N is the first DNA 5′-phos-
phoramidite to be coupled to the 2′-hydroxyl group of ribose.
18. Synthesize the 2′-branch in the trityl off mode using the modified synthesis cycle
starting from step 15 of Table 4.14.3, and utilizing the coupling times shown in Table
4.14.2, except for the first phophoramidite (0.3 M), which should have a coupling
time of 30 min.
19. Upon completion of the synthesis, dry the CPG by reverse flushing the column with
argon for 10 min. Alternatively, dry the CPG under a stream of nitrogen or argon, or
in a vacuum desiccator for 30 min.
20. Cleave the oligonucleotides from the support and deprotect the amino- and phos-
phate-protecting groups (see Support Protocol 2).
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21. Purify the bNAs from failure sequences by anion-exchange HPLC (see Support
Protocol 3) or denaturing PAGE (see Support Protocol 4) and measure coupling
efficiency by trityl color assay (see Basic Protocol 2, steps 12 to 15).
Typical PAGE profiles for the successful and unsuccessful regiospecific synthesis of a
branched Y-shaped DNA molecule are demonstrated in Figure 4.14.9.
SUPPORT
PROTOCOL 1
PREPARATION OF LCAA-CPG SUPPORTS WITH HIGH NUCLEOSIDE
LOADINGS
The method described allows for the rapid derivatization of LCAA-CPG having nucleo-
side loadings up to ∼90 µmol/g, which is 3 to 4 times the loading found in commercially
available solid supports. While commercial samples provide more than adequate yields
of bNAs (Damha et al., 1992), those with higher loadings (50 to 90 µmol/g) provide the
best results (Fig. 4.14.5). For example, the synthesis of small bNAs (i.e., trimers and
tetramers) requires that the CPG be densely loaded so that efficient branching may occur.
The protocol below, adapted from the work of Pon et al. (1999) and Damha et al. (1990),
allows for the rapid esterification of 5′-O-protected ribonucleosides and deoxyribonu-
cleosides to succinyl-LCAA-CPG. The key condensing reagent is a mixture of HATU
and 4-DMAP.
Materials
5′-O-(4,4′-Dimethoxytrityl)-N-protected-ribonucleoside or
-2′-deoxyribonucleoside (ChemGenes)
O-(7-Azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate
(HATU; PE Biosystems)
4-Dimethylaminopyridine (DMAP; 99%, Aldrich)
A B
T10 XC
1
A(i) (iii)
(iv)
TACTAA GTATGTCAAGTT
2 3 4
BPB
BPB
XC
T10
TACTAA SiCAAGTT
SiA(ii)
T10
Figure 4.14.9 20% denaturing PAGE analysis of a successful (A) and a less successful (B)
synthesis of bNAs. (A) Lane 1, pure bNA (i) prepared by the divergent synthesis method (see Basic
Protocol 3); lane 2, pure bNA (i) prepared by the convergent synthesis method (see Basic Protocol
2); lane 3, crude bNA (i) prepared by the divergent synthesis method; lane 4, running dyes (xylene
cyanol and bromphenol blue). (B) Preparative PAGE purification of bNA (iii) prepared via the
divergent (regiospecific) approach. The diminutive amount of fully branched product (iii) is due to
the incomplete desilylation of the 2′-O-TBDMS group (Si) on the RNA branching synthon, as seen
by the significant amount of (iv) that remains.
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Succinylated long-chain-aminoalkyl controlled-pore glass (succinyl-LCAA-CPG;
UNIT 3.2)
Anhydrous acetonitrile (see recipe)
Dichloromethane, reagent grade (Fisher)
Methanol, reagent grade (Fisher)
Cap A and B capping reagents (see recipes)
15-mL glass bottle with septum
1-mL syringe and needle
Wrist-action shaker
Sintered glass funnel or Buchner funnel with filter paper
Additional reagents and equipment for quantitation of released trityl groups (UNIT
3.2) and acetylation of support (UNIT 3.2; optional)
1. In a 15-mL glass bottle, combine the following:
0.1 mmol 5′-O-(4,4′-dimethoxytrityl)-N-protected-ribonucleoside or
 -2′-deoxyribonucleoside
0.1 mmol HATU
12 mg DMAP
250 mg succinyl-LCAA-CPG.
2. Cap the bottle with a septum and add 1 mL anhydrous acetonitrile via a 1-mL syringe
and needle.
3. Shake 2 to 4 hr on a wrist-action shaker at room temperature.
Do not stir the slurry with a magnetic stir bar as this will break up the glass beads into fine
particles that may clog the frit on the DNA synthesizer.
4. Vacuum filter succinyl-LCAA-CPG into a side-arm filter flask through a sintered
glass funnel or Buchner funnel with filter paper.
5. Wash the CPG sequentially with 25 mL reagent-grade dichloromethane, 25 mL
methanol, and 25 mL dichloromethane.
It has been reported that the free carboxylic groups are inconsequential and do not react
during phosphoramidite synthesis (Lyttle et al., 1997).
6. Transfer the CPG to a glass vial and dry under vacuum using in a desiccator attached
to a vacuum pump.
The derivatized CPG may be stored indefinitely at room temperature, preferably in a
vacuum desiccator.
7. Determine nucleoside loading through the quantitation of the released trityl groups
from the support-bound nucleoside (UNIT 3.2).
8. Acetylate the solid support with cap A and B capping reagents on a DNA synthesizer
using the capping cycle outlined in Table 4.14.1. Alternatively, perform capping as
described in UNIT 3.2.
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SUPPORT
PROTOCOL 2
COMPLETE DEPROTECTION OF BRANCHED OLIGONUCLEOTIDES
(DNA AND RNA)
This protocol describes the steps necessary for cleaving the bNA from the solid support
and removing the protecting groups from the heterocyclic bases and sugar-phosphate
backbone. The first step is treatment of the solid support with concentrated aqueous
ammonia to concomitantly cleave both the bNA from the support and the N-acyl and
2-cyanoethyl phosphate-protecting groups. A subsequent deprotection step with triethyl-
ammonium trihydrofluoride (TREAT-HF) cleaves the 2′-O-tert-butyldimethylsilyl
(TBDMS) protecting groups from branched oligoribonucleotides (Gasparutto et al.,
1992). The desilylated material is then precipitated directly using 1-butanol (Sproat et al.,
1995). A procedure for the quantitation of oligonucleotides is also described.
Materials
Branched oligonucleotide attached to CPG (bNA-CPG; see Basic Protocols 2 and
3)
29% ammonium hydroxide, 4°C (store up to 1 month at 4°C)
70% and 100% (v/v) ethanol, former at 4°C
DEPC-treated water (optional; APPENDIX 2A)
Autoclaved water
Triethylammonium trihydrofluoride (TREAT-HF; 98%; Aldrich)
3 M sodium acetate, pH 5.5 (APPENDIX 2A)
1-Butanol, analytical grade, 4°C
1.5-mL screw-cap microcentrifuge tubes with O-ring seals (preferred)
Wrist-action shaker
Speedvac evaporator (Savant)
Double-beam UV spectrophotometer, calibrated
Cleave and deprotect oligonucleotide
1. Transfer bNA-CPG to a 1.5-mL screw-cap microcentrifuge tube, preferably with an
O-ring seal.
2. Add 750 µL cold 29% ammonium hydroxide and 250 µL of 100% ethanol, screw the
cap on tightly, and incubate 24 to 48 hr at room temperature on a wrist-action shaker.
If the branched oligonucleotide sequence contains isobutyryl-protected guanosine nucleo-
tides, then deprotection must proceed for ≥48 hr, room temperature.
The ammonium hydroxide should be relatively fresh (<1 month old). Seal the cap on the
ammonium hydroxide solution tightly and store at 4°C.
3. Microcentrifuge 1 min at maximum speed, room temperature, and cool 30 min on
dry ice or 1 to 2 hr at −20°C.
The contents must be cooled before the screw cap is released to prevent volatile ammonium
hydroxide from boiling over, which could result in loss of product.
4. Remove supernatant and transfer to a fresh 1.5-mL microcentrifuge tube.
5. Wash CPG pellet with 500 µL of 100% ethanol, microcentrifuge to settle the CPG,
and transfer the supernatant wash to a second 1.5-ml tube. Repeat two more times
(total four tubes).
6. Cool all four tubes for 1 hr on dry ice, then dry in a Speedvac evaporator.
Introducing the vacuum too quickly will lead to bumping of the ammonia solution and
sample loss.
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7. Pool in a total of 1 mL water. For branched RNAs, use DEPC-treated water that has
been autoclaved to remove residual DEPC.
The product is a crude deprotected branched DNA or partially deprotected branched RNA.
For RNA, DEPC-treated water should be used in all subsequent steps.
Quantitate oligonucleotide
8. Dilute crude bNA 10 or 100 fold with autoclaved water and measure the absorbance
at 260 nm (A260) on a calibrated, double-beam, UV spectrophotometer using auto-
claved water as a reference.
If using a single-beam spectrophotometer, a baseline should be run with a sample
containing autoclaved water (blank).
9. Determine the concentration of the stock solution using the dilution factor and Beer’s
Law (A260 = εbc), where ε is the molar extinction coefficient, b is the UV cell
pathlength (typically 1 cm), and c is the concentration of oligonucleotide present.
The molar extinction coefficients (liter/mol cm) and molecular weights of the oligonu-
cleotides can be obtained from http://paris.chem.yale.edu/extinct.html and
 http://medstat.med.utah.edu/masspec/oligoii.htm.
Cleave 2′-O-TBDMS group
10. Evaporate bRNA samples (step 7) using a Speedvac evaporator and resuspend in 5
µL TREAT-HF per A260 unit (step 8).
11. Cover the microcentrifuge tubes with aluminum foil and incubate 24 to 48 hr at room
temperature on a wrist-action shaker.
Alternatively, the 2′-O-TBDMS group may be removed using a mixture of TREAT-HF and
N-methylpyrrolidinone according to the method of Wincott et al. (1995).
For large bRNAs (≥10-mers):
12a. Precipitate the oligonucleotides directly from the desilylation reaction by adding 25
µL of 3 M sodium acetate, pH 5.5, followed by 1 mL cold analytical-grade 1-butanol.
Vortex 1 min and cool 3 to 6 hr at −20°C.
A white precipitate should be clearly visible after addition of 1-butanol.
13a. Microcentrifuge 10 min at maximum speed, 4°C, carefully remove the supernatant,
and wash the white pellet twice with 500 µL cold 70% ethanol each.
Disruption of the pellet during washing steps could result in loss of sample.
14a. Dry the pellet in a Speedvac evaporator, resuspend in 1 ml autoclaved water, and
requantitate the amount of crude oligonucleotide (steps 8 and 9).
Once the 2′-O-TBDMS group has been removed, the fully deprotected RNA is sensitive to
nucleases and base hydrolysis, which will cause strand cleavage. In order to prevent this,
special considerations for working with RNA (APPENDIX 2A) must be observed. Water used
for RNA dissolution and buffer preparation should be of the highest quality available
(Milli-Q) and should be treated with DEPC.
For small bNAs (<10-mers):
12b. Quench the desilylation reaction with an equal volume of autoclaved water and
evaporate in a Speedvac evaporator. Resuspend in 1 mL autoclaved water and
requantitate the amount of crude oligonculeotide (steps 8 and 9).
Shorter sequences (i.e., trimers and tetramers) do not precipitate efficiently.
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SUPPORT
PROTOCOL 3
ANALYSIS AND PURIFICATION OF BRANCHED OLIGONUCLEOTIDES
USING ANION-EXCHANGE HPLC
Branched oligonucleotides may be easily and efficiently analyzed and purified from the
crude mixture by anion-exchange HPLC as described below (Fig. 4.14.6). bNAs of high
purity are attainable (>95%; Fig. 4.14.10). The bNA of interest can be readily isolated
from the reaction mixture failure sequences. The resultant product is precipitated directly
by the addition of 1-propanol (Sproat et al., 1995). This direct precipitation method works
very well for the direct isolation of large bNAs (>10 nt). Smaller bNAs do not precipitate
out efficiently and must be further purified by size-exclusion chromatography (or re-
versed-phase Sep-Pak cartridges) subsequent to HPLC separation. As an alternative to
HPLC purification, the bNAs may be purified by denaturing PAGE (see Support Protocol
4).
Characterization of the bNAs is conveniently done via MALDI-TOF-MS as described in
UNIT 10.1. The matrix and co-matrix typically used are 6-aza-2-thiothymine (ATT) and
dibasic ammonium citrate, respectively (Lecchi et al., 1995).
The branched nature of the molecules may also be confirmed via the yeast debranching
enzyme (yDBR), a phosphodiesterase specific to hydrolysis of the 2′,5′-phosphodiester
bond of oligonucleotides that contain vicinal 2′,5′- and 3′,5′-phosphodiester linkages
(Nam et al., 1994; Ooi et al., 2001). Nucleoside composition analysis of bNA is carried
out using snake venom phosphodiesterase (SVPD) according to the method of Eadie et
al. (1987; UNIT 10.6). This enzyme cleaves bDNA or bRNA from the 3′ termini yielding
5′-monophosphates, which can then be converted to their constituent nucleosides by in
situ treatment with alkaline phosphatase (AP). The resulting nucleoside mixture is
analyzed by reversed-phase HPLC as described in UNIT 10.5. Alternatively, bNA can be
digested with nuclease P1 from Penicillium citrinum, an endonuclease that cleaves bNA
to produce the constituent nucleoside 5′-monophosphates and its branch core trinu-
cleoside diphosphate—i.e., A(2′p5′N)3′p5′N (Damha et al., 1992). The released branched
trinucleoside diphosphate structure can be readily synthesized (see Basic Protocol 2) and
used as a standard during HPLC analysis of the enzyme digest (UNIT 10.6).
NOTE: For branced RNAs, use DEPC-treated water throughout (APPENDIX 2A).
95% purity
0.00
AU
10.00 20.00 30.00 40.00
Time (min)
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Figure 4.14.10 Analysis of the purity of a bNA synthesized via the convergent strategy. Purification
was conducted using anion-exchange HPLC (see Support Protocol 3) with linear gradient 2 (Table
4.14.4). The chromatogram was obtained using the same conditions.
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Materials
Deprotected branched oligonucleotide (see Support Protocol 2)
Autoclaved water
1 M LiClO4 (see recipe)
Reagent-grade 1-propanol, 4°C (>5-mers; Fisher)
Sephadex G-25 columns (Amersham Pharmacia Biotech) or Sep-Pak cartridges
(Waters Chromatography) for <5-mers
Nuclease P1 buffer (see recipe)
0.3 U/µL Penicillium citrinum nuclease P1 (NP1)
9 U/µL alkaline phosphatase (AP)
0.1 M triethylammonium acetate (TEAA), pH 7.0
Acetonitrile, HPLC grade
50°C water bath or heating block
High-performance liquid chromatograph (HPLC) with:
 Anion-exchange column (7.5 × 75–mm Waters Protein-Pak DEAE-5PW)
 UV detector with adjustable range or dual-wavelength detection
 Sample loop
 Column heater
 Reversed-phase C18 column (e.g., Whatman Partisil ODS-2, 10-m, 4.6 ×
250–mm; Chromatographic Specialties)
Syringe
Speedvac evaporator (Savant)
Additional reagents and equipment for reversed-phase chromatography (UNIT 10.1 &
10.6) and quantitation of bNAs by UV spectrophotometry (see Support Protocol
2)
Analyze bNAs by anion-exchange HPLC
1. Aliquot 0.3 to 0.6 A260 units of deprotected branched oligonucleotide (25 to 100 µL
volume) into a sterile 1.5-mL microcentrifuge tube.
2. Heat the sample 1 min in a 50°C water bath or heating block.
Heating the sample disrupts any intramolecular secondary structures.
3. To settle any particulates, microcentrifuge 2 min at maximum speed, room tempera-
ture.
It is important to avoid loading any small particulates into the injector of the HPLC as
they may clog the injection loop.
4. Preequilibrate HPLC anion-exchange column with initial buffer conditions (Table
4.14.4) and set the UV detector wavelength to 260 nm.
Table 4.14.4 Conditions for Separation of bNAs by Anion-Exchange HPLCa
Length of bNA
(nt) Gradient
% Buffer A
(H2O)
% Buffer B
(1 M LiClO4) Run time (min)
<5 1 100-90 0-10 60
6-15 2 100-80 0-20 60
>15 3 90-80 10-20 60
aPerformed on a Waters 7.5 × 75–mm Protein Pak DEAE-5PW column.
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5. Load the sample into the sample loop using an appropriate syringe and inject. Elute
bNA at 50°C with a flow rate of 1 mL/min and the gradient and run time specified
in Table 4.14.4. Record the chromatogram.
The branched DNA or RNA product should be very well resolved from the extended linear
failure sequences and other failure sequences present in the crude mixture. Full-length
bNAs elute last (i.e., highest retention time). Typical chromatograms for a 31-mer bDNA
and 25-mer bRNA are demonstrated in Figure 4.14.6A and C. Note the excellent separation
between the bNA of interest and the failure sequences.
Purify bNAs by anion-exchange HPLC
6. Dissolve 40 to 60 A260 units crude bNA mixture in 1 mL autoclaved water. Heat and
microcentrifuge as in steps 2 to 3.
Loading >60 A260 units may overload the column and compromise the separation of the
bNA from the linear failure sequences.
7. Run the sample as described (steps 4 and 5), but set the detector to 290 nm and collect
1-ml fractions from the peaks of interest in sterile 1.5-mL microcentrifuge tubes.
The detector wavelength is set to 290 nm in order to avoid saturation of the detector signal.
If the HPLC is equipped with a detector capable of monitoring dual wavelengths, monitor
both the 260- and 290-nm profiles.
The anticipated retention time should be very similar to that obtained during routine HPLC
analysis.
8. Pool peak fractions and dry them in a Speedvac evaporator. Add 250 µL autoclaved
water.
For large bRNAs (≥5-mers):
9a. Precipitate from perchlorate salts (in sample) by adding 4 vol (1 mL) reagent-grade
cold 1-propanol and cooling 4 to 6 hr at −20°C.
Lithium perchlorate (LiClO4) is much more soluble in organic solvents than other per-
chlorate salts, making precipitation easy and efficient, and thus preventing a final desalting
step. The DNA or RNA isolated is in its lithium salt form.
10a. Microcentrifuge 10 min at maximum speed, room temperature, carefully remove
the supernatant, and wash the white pellet twice with 500 µL cold 1-propanol.
Disrupting the pellet during washing steps can result in loss of sample.
11a. Dry in a Speedvac evaporator, resuspend in 1 mL autoclaved water, and proceed to
step 12.
For small bNAs (<5-mers):
9b. Desalt by size-exclusion chromatography on Sephadex G-25 columns according to
manufacturer’s instructions or by reversed-phase chromatography on Sep-Pak car-
tridges (UNIT 10.1). Proceed to step 12.
Small bNAs do not precipitate out of solution efficiently.
Characterize bNAs
12. Quantitate the bNA sample by UV spectrophotometry (see Support Protocol 2, steps
8 and 9).
13. Dissolve 0.5 A260 units bNA in 20 mL of nuclease P1 buffer.
14. Add 3 µL (0.9 U) NP1 and 1 µL (9 U) AP. Mix well and incubate 24 hr at 37°C.
The alkaline phosphatase may be contaminated with adenosine deaminase, which converts
adenosine into inosine. The retention time of an appropriate inosine nucleoside control
should be obtained prior to HPLC analysis of the digestion mixture (UNIT 10.6).
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15. Dry the sample in a Speedvac evaporator and dissolve residue in 15 µL autoclaved
water.
16. Analyze the mixture by reversed-phase HPLC on a C18 column using the mobile
phases 0.1 M TEAA, pH 7.0, and acetonitrile with the gradient described in UNIT 10.6.
17. Calculate the relative ratios of nucleoside to branched trinucleotide diphosphate by
dividing the area of each peak by the extinction coefficients specified in UNIT 10.6.
The extinction coefficient for the branched trinucleotide diphosphate may be calculated
using the oligonucleotide extinction coefficient calculator at http://paris.chem.yale.edu/
extinct.html. The extinction coefficients for bDNA and bRNA are assumed to be the same
as their linear counterparts.
SUPPORT
PROTOCOL 4
ANALYSIS AND PURIFICATION OF BRANCHED OLIGONUCLEOTIDES
BY DENATURING PAGE
A method for the analysis and purification of bNAs by denaturing polyacrylamide gel
electrophoresis (PAGE) is described (also see UNIT 10.4 and APPENDIX 3B). PAGE is a very
convenient way to assess efficiency of bNA synthesis since the molecular weight of
oligonucleotides bound on the solid support more than doubles after a convergent
branching reaction—e.g., reaction of neighboring decathymidylic acid chains with
bisphosphoramidite synthon S.3 to give a 21-unit-long bNA molecule (Fig. 4.14.4 and
product ii in Fig. 4.14.6B). This generates a gap between the desired bNA product and its
precursor molecules, greatly facilitating the separation process. Any type of standard
laboratory electrophoresis equipment may be utilized. Most bNAs of >10 nucleotides in
length are very well resolved on a 20% denaturing polyacrylamide gel. If shorter
sequences must be purified, better resolution is achieved with a 24% denaturing polyacryl-
amide gel. Setup and polymerization of the gel along with electrophoretic separation
conditions are described. The resultant bands may be visualized by UV shadowing and
photographed. A technique for the rapid extraction of oligonucleotides from the gel matrix
is also described (Chen and Ruffner, 1996).
Materials
20% (w/v) denaturing acrylamide gel solution (see recipe)
Deprotected branched oligonucleotide sample, dry (see Support Protocol 2)
Formamide loading buffer (see recipe)
Gel extraction buffer (see recipe)
Running dye (see recipe)
Gel electrophoresis equipment (APPENDIX 3B) with:
 16 × 18–cm glass plates
 Spacers: 0.75 mm (analysis) or 1.5 mm (purification)
 Gel combs: 0.75 mm thick with 12 to 20 wells (analysis) or 1.5 mm thick with
one to three large wells (purification)
Sonicator or ∼50°C water bath (optional)
20 × 20–cm silica-coated thin-layer chromatography (TLC) plate with fluorescent
indicator (e.g., Kieselgel 60 F254 aluminum sheets)
Handheld UV lamp (254 nm)
Camera equipped with UV filter (optional)
90°C water bath or heating block (optional)
UV shadow box
Wrist-action shaker (optional)
Speedvac evaporator (Savant)
Sephadex G-25 (Amersham Pharmacia Biotech) or reversed-phase cartridges (e.g.,
Sep-Pak cartridges; Waters Chromatography)
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Additional reagents and equipment for denaturing PAGE (UNIT 10.4 and APPENDIX
3B), reversed-phase chromatography using Sep-Pak cartridges (UNIT 10.1), UV
spectrophotometry (see Support Protocol 2), MALDI-TOF-MS (UNIT 10.1), and
enzymatic digestion (see Support Protocol 3)
CAUTION: Acrylamide and N,N′-methylenebisacrylamide are neurotoxins. Prepare all
solutions containing these two reagents in a fume hood. Minimize exposure and contact
to both crystalline forms and solutions by conducting all handling (including weighing)
in a well-ventilated area and wearing disposable gloves at all times.
Analyze bNAs by denaturing PAGE
1. Assemble a gel sandwich using 16 × 18–cm glass plates separated by 0.75-mm
spacers.
See APPENDIX 3B and UNIT 10.4 for a thorough description of denaturing PAGE.
2. Transfer 30 mL of 20% denaturing acrylamide gel solution to an Erlenmeyer flask
and add 200 µL fresh 10% (w/v) APS immediately followed by 20 µL TEMED. Swirl
and degas the solution by attaching the Erlenmeyer flask to a house vacuum line.
Maintain rapid stirring to avoid bumping.
The gel solution may also be degassed prior to APS and TEMED addition by placing the
20% acrylamide gel solution on a sonicator for 5 to 10 min. If using larger glass plates,
adjust the volumes of acrylamide, APS, and TEMED accordingly.
3. Pour the solution between the plates, insert a 0.75-mm-thick comb, and allow gel to
polymerize (30 to 45 min).
4. Place gel in electrophoresis apparatus, removing the comb and bottom spacer, rinse
the wells, and prerun the gel 30 min at 500 V, room temperature.
5. Dissolve 0.6 A260 units deprotected bNA sample in 10 µL formamide loading buffer.
If the dissolution process is not immediate, place the sample in a sonicator bath 1 to
2 min or heat the samples briefly at ∼50°C.
6. Load the samples into the wells. Load an equal amount of running dye in the first and
last well as an external reference marker. Run the gel at 500 V until the bromphenol
blue dye is 3⁄4 of the way down the gel.
7. Disassemble the glass plates and wrap the gel in plastic wrap. Place the wrapped gel
over a 20 × 20–cm silica-coated TLC plate with fluorescent indicator and visualize
the bands by shining a handheld UV lamp over the gel. Take a picture of the gel using
a camera equipped with a UV filter.
CAUTION: Wear safety glasses to avoid eye burn.
A typical crude bNA reaction mixture will consist of at least three bands as shown in Figures
4.14.6 and 4.14.7. The fastest-migrating band is the linear precursor sequence (S.7; Fig.
4.14.4), followed by the extended isomeric failure sequences (S.9a-b for the synthesis of
V-shaped bNAs and S.11a-b for the synthesis of Y-shaped bNAs), and finally the products
(S.8 and S.10). If the coupling efficiencies between successive nucleotides is less than
optimal, a ladder of failure sequences will be evident below the extended branch failure
and linear sequences.
Note that the extended isomeric failure sequences are a mixture of regioisomers (S.9a-b
and S.11a-b) that are sometimes resolved into two close-moving bands (this is also evident
by HPLC analyses). The slowest of the predominant bands is the bNA of interest. If linear
markers are run alongside the purified bNA, one observes that bNA has retarded mobility
relative to a linear oligonucleotide of identical composition (length and sequence compo-
sition). This is due to the increased frictional effects of the bNA relative to the linear
sequences as they move through the highly cross-linked gel environment.
Current Protocols in Nucleic Acid Chemistry Supplement 9
4.14.25
Synthesis of
Modified
Oligonucleotides
and Conjugates
Purify bNAs by denaturing PAGE
8. Assemble and run a preparative gel as for the analytical gel (steps 1 to 6) with the
following modifications:
a. Increase gel thickness (spacers and comb) to 1.5 cm and scale up volume of gel to
50 mL gel solution, 350 µL APS, and 35 µL TEMED.
b. Use up to 100 A260 units crude bNA dissolved in 100 µL formamide loading buffer.
c. Use a comb with one large well to purify 60 to 100 A260 units, one well of a two-well
comb for 30 to 60 units, and one well of a three-well comb for <30 units.
9. Disassemble the glass plates, remove the gel, and wrap it in plastic wrap. Place the
wrapped gel over a silica-coated TLC plate and visualize the bands by shining UV
light over the gel. If desired, photograph the gel using a camera equipped with a UV
filter.
CAUTION: Wear safety glasses to avoid eye burn.
10. Excise the slowest moving band and place the gel piece into a sterile 15-mL tube.
Crush the gel piece using a sterile spatula and soak in 3 mL gel extraction buffer.
11. Heat 5 min in a 90°C water bath or heating block and rapidly freeze 5 min in dry ice.
Thaw contents rapidly at 90°C and centrifuge 10 min at maximum speed × g in a
tabletop centrifuge to settle the crushed gel pieces. Alternatively, after extracting in
3 mL gel extraction buffer (step 10) or water, shake the slurry 12 to 16 hr at room
temperature on a wrist-action shaker.
The rapid “crush and soak” method described has been outlined in a paper by Chen and
Ruffner (1996).
12. Extract the supernatant and dry in a Speedvac evaporator. Desalt on a Sephadex G-25
column according to manufacturer’s instructions, or via reversed-phase chromatog-
raphy using Sep-Pak cartridges according to UNIT 10.1.
13. Quantitate the amount of bNA recovered via UV spectrophotometry (see Support
Protocol 2, steps 8 and 9).
14. Characterize bNAs by MALDI-TOF-MS (UNIT 10.1) and/or enzymatic digestion of the
constituent nucleotides with SVPD/AP and NP1/AP (see Support Protocol 3).
REAGENTS AND SOLUTIONS
Use deionized, double-distilled water in all recipes and protocol steps. For common stock solutions, see
APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX.
Acetonitrile, anhydrous
Predry by refluxing over reagent-grade phosphorus pentoxide (Fisher) followed by
refluxing and distillation over calcium hydride (Aldrich) under inert atmosphere.
Prepare fresh before each use.
Alternatively, low-water acetonitrile suitable for use on a DNA synthesizer can be purchased
(VWR Canlabs or BDH) and used as such, or refluxed and distilled from calcium hydride
under inert atmosphere.
Cap A capping reagent
Prepare anhydrous 2,4,6-collidine (Aldrich) by refluxing and distillation over
calcium hydride. Store up to 6 months at room temperature under inert atmosphere
over activated 4A molecular sieves. Before use mix 1 part dry 2,4,6-collidine with
1 part acetic anhydride and 8 parts anhydrous THF (see recipe).
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Cap B capping reagent
Prepare anhydrous N-methylimidazole (Aldrich) by stirring over calcium hydride
for 24 hr, followed by vacuum distillation. Dilute to 16% (v/v) in anhydrous THF
(see recipe). Store up to 6 months at room temperature under inert atmosphere over
activated 4A molecular sieves.
Denaturing acrylamide gel solution, 20% (w/v)
20 g acrylamide
1 g N,N′-methylenebisacrylamide
21.02 g electrophoresis-grade urea (final 7 M)
5 mL 10× TBE electrophoresis buffer (APPENDIX 2A)
H2O to 50 mL
Store up to 1 to 2 months at 4°C
CAUTION: Acrylamide and N,N′-methylenebisacrylamide are neurotoxins. Prepare all
solutions in a well-ventilated fume hood, and take precautions to minimize exposure. Wear
gloves at all times.
To aid in dissolution, the acrylamide solution can be heated in a warm (<50°C) water bath
with constant stirring. Do not overheat as this will cause the acrylamide to polymerize.
Detritylation solution
3% (w/v) trichloroacetic acid (TCA, 99%, Aldrich)
1,2-Dichloroethane (analytical grade, Fisher)
Store up to 6 months at room temperature
Diisopropylethylamine (DIPEA), anhydrous
Dry by mild heating (50° to 60°C) and stirring 16 hr over calcium hydride followed
by distillation under vacuum. Store up to 2 to 4 months at 4°C over 4A activated
molecular sieves in septum-sealed bottles.
Alternatively, 99.5% redistilled DIPEA can be purchased (Aldrich) and kept anhydrous by
storage over activated 4A molecular sieves up to 1 year at 4°C.
Formamide loading buffer
Deionize 10 mL formamide by adding 1 g mixed bed resin (Bio-Rad) and stirring
30 min. Filter through Whatman filter paper. Mix 4 vol deionized formamide with
1 vol of 10× TBE electrophoresis buffer (APPENDIX 2A). Store up to 1 year at −20°C.
Gel extraction buffer
363 mg Tris base (final 30 mM)
1.75 g NaCl (final 300 mM)
112 mg disodium EDTA (final 3 mM)
H2O to 100 mL
Store up to 6 months at 4°C
pH to 7.5
Lithium perchlorate (LiClO4), 1 M
Dissolve 106.4 g LiClO4 (99%, Aldrich) in 1 liter water. Store up to 1 month at room
temperature. Filter through a 0.45-µm filter before use.
Nuclease P1 buffer
1.21 g Tris base (final 0.1 M Tris⋅Cl)
13.6 mg ZnCl2 (final 1 mM)
H2O to 100 mL
Adjust pH to 7.2 with HCl
Store up to 6 months at −20°C
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Oxidant solution
1.23 g iodine crystals (0.1 M)
25:20:2 (v/v/v) tetrahydrofuran/pyridine/water
Store up to 6 months at room temperature
Running dye
9.8 mL deionized formamide
0.2 mL 10× TBE electrophoresis buffer (APPENDIX 2A)
10 mg xylene cyanol (final 0.1%)
10 mg bromphenol blue (final 0.1%)
Store up to 1 year at −20°C
Tetrahydrofuran (THF), anhydrous
Dry by continuous reflux and distillation over sodium metal and benzophenone
under an inert atmosphere until a purple color persists. Prepare fresh before each
use.
Triethylamine/acetonitrile, 4:6 (v/v)
Dry triethylamine by refluxing and distillation over calcium hydride. Store up to 1
year at  4°C over activated 4A molecular sieves. Mix 8 mL anhydrous triethylamine
and 12 mL anhydrous acetonitrile (see recipe) in a septum bottle and seal. Prepare
fresh. To use, withdraw via syringe through the septum.
COMMENTARY
Background Information
Discovery and applications of bNAs
The body of work devoted to branched nu-
cleic acids (bNAs) indicates that they are of
current interest in chemistry and biochemistry.
Branched ribonucleic acids (bRNAs) were first
detected in nuclear RNA in 1983 (Wallace and
Edmonds, 1983). It was later discovered that an
RNA “lariat” is the first biochemical interme-
diate in the splicing of precursor messenger
RNA (Ruskin et al., 1984). Several other bRNA
structures such as Y-shaped trans-splicing in-
termediates and multicopy single-stranded
DNAs (msDNA) were subsequently discov-
ered in eukaryotes and prokaryotes, respec-
tively (Yee et al., 1984; Inouye et al. 1987).
These branched molecules all contain a com-
mon structural feature, namely vicinal 2′,5′-
and 3′,5′-phosphodiester bonds at a branch
point nucleotide. A novel polypeptide termed
the RNA lariat debranching enzyme selectively
hydrolyzes the 2′,5′-phosphodiester bond at the
branch point of excised intron lariats, thus con-
verting them into linear molecules (Ruskin and
Green, 1985; Chapman and Boeke, 1991; Nam
et al., 1994).
The novelty of bRNAs has raised interest as
to their possible role in regulating RNA proc-
essing. Recently, there has been increasing in-
terest in synthetic bDNA and bRNA for use in
diagnostic applications (Urdea et al., 1991) and
biosensor development (Uddin et al., 1997), as
tools for studying mRNA splicing (Carriero et
al., 2001) and debranching (Nam et al., 1994;
Ooi et al., 2001), and as “molecular anchors”
for inducing the formation of novel triplex (e.g.,
Hudson et al., 1995) and tetraplex structures
(Robidoux et al., 1997).
Chemical synthesis of bRNA
The stepwise assembly of the vicinal 2′,5′-
and 3′,5′-internucleotide linkages present in
bRNA via traditional phosphotriester methods
can be difficult, as cyclic phosphate may be
formed (see Damha et al., 1992, and references
therein). This problem was circumvented by
using phosphodiester intermediates, which are
more stable to nucleophilic attack by vicinal
2′-OH groups relative to phosphotriesters.
Short bRNA molecules were first prepared
by solution-phase methods. Ogilvie and co-
workers originally prepared branched tri- and
tetranucleotides having identical nucleotides at
the branch point 2′ and 3′ positions (symmetric
bRNA; Damha et al., 1985; Damha and
Ogilvie, 1988). Their method was also adapted
to the synthesis of bRNA isomers having dif-
ferent nucleotide units at the 2′ and 3′ positions
(Damha and Ogilvie, 1988). Regiospecific syn-
thesis of a tetranucleotide of natural branch
point sequence was performed by Kierzek et al.
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(1986) by solution-phase phosphoramidite
chemistry. Chattopadhyaya and co-workers
have focused on several strategies for the syn-
thesis of small bRNA and RNA lariats with
self-cleavage properties (Rousse et al., 1994).
The authors’ group has been describing in
detail a methodology for the solid-phase syn-
thesis of Y-shaped RNAs and DNAs, in which
the branch point adenosine is linked to identical
oligonucleotide chains via vicinal 2′,5′- and
3′,5′-phosphodiester linkages. Hyperbranched
or “dendritic” structures have also been synthe-
sized from this laboratory (Hudson and Damha,
1993; Hudson et al., 1998). The synthetic con-
vergent strategy is based on the discovery that
nucleoside 2′,3′-O-bisphosphoramidite syn-
thons react with adjacent solid-support-bound
chains yielding symmetric V-like molecules.
Synthesis is then continued in the 3′-to-5′ di-
rection from the apex of the V to yield Y-shaped
structures. This method was adapted to the
synthesis of bRNAs with 2′ and 3′ chains of
different base composition (Ganeshan et al.,
1995). All other synthetic strategies reported so
far for the regiospecific assembly of branched
oligonucleotides mimicking the natural lariat
structures are based upon solution-phase phos-
photriester methods, except for the recent work
by Sproat et al. (1994), who use a divergent
solid-phase phosphoramidite strategy. This
strategy has permitted the synthesis of medium-
sized branched oligoribonucleotides; however,
it requires the use of nonstandard monomers
and branch-point synthons. Given this limita-
tion, and those of the authors’ current methods,
alternative strategies for the regiospecific syn-
thesis of branched oligonucleotides were
sought. This led ultimately to the synthesis of
multi-copy single-stranded DNA, a peculiar
nucleic acid that is produced in E. coli and M.
xantus (Damha and Braich, 1998).
In this unit, general procedures for both
convergent and divergent solid-phase synthesis
of branched oligonucleotides are presented.
The conditions of the branching reactions are
crucial to the ultimate success of the overall
procedure, and the protocols described in this
unit should be followed carefully. In spite of
these areas of caution, bNA sequences can now
be prepared routinely using, for the most part,
commercially available reagents and standard
laboratory equipment. The novice should have
no hesitation in setting forth!
Compound Characterization
Analysis of crude and purified bNAs is con-
veniently carried out via anion-exchange
HPLC (see Support Protocol 3). The buffer
concentration required for the elution of bNA
is dependent upon the molecular weight and
charge of the molecule being purified (Table
4.14.4). Separation of bNA from failure se-
quences is greatly facilitated by the relatively
large molecular weight of the bNA species. Gel
electrophoresis is another convenient way to
isolate/purify bNA fragments (see Support Pro-
tocol 4). In this case, the bNA of interest exhib-
its significant retarded mobility relative to the
failure sequences as a result of frictional effects
as the bNA molecules migrate through the
cross-linked gel environment. Further charac-
terization is conducted by MALDI-TOF-MS
(UNIT 10.1) using 6-aza-2-thiothymine (ATT) and
dibasic ammonium citrate as matrices (Lecchi
et al., 1995). Nucleoside composition analysis
is conducted via enzymatic hydrolysis with the
exonuclease snake venom phosphodiesterase
(Eadie et al., 1987; UNIT 10.6) and the endonu-
clease nuclease P1 (see Support Protocol 3).
The yeast debranching enzyme (yDBR), a
phosphodiesterase specific to the 2′,5′-phos-
phodiester bond of oligonucleotides containing
vicinal 2′,5′- and 3′,5′-phosphodiester link-
ages, may also be used to confirm the branched
nature of the molecules according to the
method of Ooi et al. (2001).
Critical Parameters and
Troubleshooting
Basic Protocol 1
The synthesis of the branch synthon (S.3)
from 5′-O-DMTr-N6-benzoyl-riboadenosine is
extremely moisture sensitive. Thus, it is im-
perative that all solvents, reagents, and appara-
tuses (e.g., syringes, needles, reaction vessel)
be anhydrous. The phosphitylating reagent
(stored at −20°C) should be warmed to room
temperature in a desiccator prior to use. If the
isolated yield of S.3 is significantly lower than
expected, verify that the phosphitylating chlo-
rophosphoramidite is a clear viscous liquid, and
that no crystalline material is present (this resi-
due is indicative of hydrolysis).
Basic Protocol 2
There are two important considerations
when synthesizing bNA by the convergent ap-
proach. Firstly, the yield of bNA is dependent
upon the molar concentration of the branching
bisphosphoramidite synthon S.3. Dilute solu-
tions (0.03 M) of S.3 must be employed to
maximize coupling with adjacent CPG-bound
oligonucleotide chains (branching). If higher
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concentrations are used, yields of branched
products are reduced, and mainly extended iso-
meric side products are formed. The efficiency
of the branching reaction can be assessed dur-
ing synthesis by quantitation of the trityl cat-
ions released immediately before and after the
branching reaction. Theoretically, 100%
branch formation should give an apparent cou-
pling yield of 50% since the trityl absorption
following branching should be half of the pre-
vious absorption (during branching two nu-
cleotide chains become joined to a single
bisphosphoramidite synthon). Thus, trityl
yields significantly greater or less than 50%
indicate little branch formation (e.g., 80% ap-
parent trityl yield indicates the formation of
mainly the extended isomeric compounds). It
is important to prepare the bisphosphoramidite
stock solution (0.03 M) using at least 100 mg
S.3. This ensures that (unavoidable) traces of
moisture will not use up significant amounts of
bisphosphoramidite during the branching step
and reduce the overall yield of synthesis. The
purity of the bisphosphoramidite can be as-
sessed prior to use via TLC analysis or 31P-
NMR. If partial decomposition has occurred,
or if the branching reactions during synthesis
are poor, the compound should be rechroma-
tographed as described (see Basic Protocol 1).
Secondly, solid supports having a high de-
gree of derivatization (>50 µmol/g) provide the
best results for the synthesis of short bNA
fragments (<7 nt). This is because highly sub-
stituted supports ensure the appropriate dis-
tance between the reactive 5′-OH end groups
of the immobilized oligonucleotide chains.
Supports with a nucleoside loading of 30 to 50
µmol/g give very good results for the synthesis
of medium-size branched oligonucleotides.
Basic Protocol 3
The divergent approach requires synthesis
of a linear oligonucleotide chain followed by
backward synthesis from the 2′-hydroxyl of an
internal ribonucleotide residue. This is carried
out with commercially available inverted nu-
cleoside 5′-phosphoramidites. Key to the suc-
cess of this synthesis is the ability to cleave the
2′-O-silyl protecting group of the internal ri-
bonucleotide residue and the use of an excess
of the first inverted 5′-phosphoramidite reagent
to force the branching reaction to a maximal
extent. This is in sharp contrast to the conver-
gent strategy, where branching requires a deli-
cate control of reaction conditions.
Incomplete removal of the 2′-O-TBDMS
group from the RNA branch point (Fig. 4.14.8)
results in the accumulation of the linear DNA-
RNA-DNA precursor (S.12), which is easily
detected by HPLC and PAGE. To ensure com-
plete 2′-O-desilylation of the CPG-bound oli-
gonucleotide, it is essential to use fresh TBAF
reagent and to introduce the TBAF solution
slowly to the synthesis column (via syringe),
pushing and pulling the piston slightly to dis-
place the CPG beads stuck at the base of the
column. This allows all of the CPG-bound
oligonucleotide to come in contact with the
TBAF reagent. It is important not to expose the
CPG-bound bNA to the TBAF reagent for >10
min, as prolonged treatment results in signifi-
cant cleavage of the oligonucleotide from the
solid support. After washing steps, the first
inverted phosphoramidite is introduced as a 0.3
M acetonitrile solution (as opposed to 0.1 M
for all other DNA 3′- and 5′-phosphoramidite
couplings) and allowed to react with the CPG-
bound oligomer for 30 min (as opposed to 90
and 120 sec for all  other DNA phos-
phoramidites).
Anticipated Results
The anticipated results of a convergent bNA
synthesis are provided in Figures 4.14.6 and
4.14.7. Syntheses carried out on a 1-µmol scale
will characteristically yield 50 to 80 A260 units
crude material, while the isolated yields (bNA)
generally fall in the range of 5 to 20 A260 units.
bNAs that have been purified by anion-ex-
change HPLC are of high purity, usually >95%
(Fig. 4.14.10). In the case of divergent bNA
synthesis, typical crude yields are in the range
of 50 to 100 A260 units. A standard gel analysis
of bNA prepared by the divergent method is
shown in Fig. 4.14.9. After HPLC or gel puri-
fication, 5 to 20 A260 units of bNA are typically
recovered from divergent syntheses (slightly
higher yields are obtained with HPLC). As for
convergent synthesis, purity is >95%.
Time Considerations
Provided that all reagents and materials re-
quired for each step are available, most of the
procedures are simple and rapid. The synthesis
of S.3 from 5′-DMTr-N6-benzoyl-riboadenos-
ine requires 2 to 4 hr to complete, including the
workup. The reaction should not be allowed to
proceed overnight, as decomposition may oc-
cur. Column chromatography requires ∼1 to 2
hr including setup. Ideally, column purification
should be conducted immediately following
the phosphitylation reaction.
When the branching synthon S.3 and all the
other phosphoramidite derivatives are ready to
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use, the time required to prepare, purify, and
isolate a Y-shaped RNA or DNA via the con-
vergent approach is 3 days and 4 to 6 days,
respectively. The preparation of bNA via the
divergent approach requires 3 days or more.
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